AU2002221096A1 - Medicinal compositions improved in solublity in water - Google Patents
Medicinal compositions improved in solublity in waterInfo
- Publication number
- AU2002221096A1 AU2002221096A1 AU2002221096A AU2109602A AU2002221096A1 AU 2002221096 A1 AU2002221096 A1 AU 2002221096A1 AU 2002221096 A AU2002221096 A AU 2002221096A AU 2109602 A AU2109602 A AU 2109602A AU 2002221096 A1 AU2002221096 A1 AU 2002221096A1
- Authority
- AU
- Australia
- Prior art keywords
- solublity
- water
- medicinal compositions
- compositions improved
- improved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000375601 | 2000-12-11 | ||
| JP2000-375601 | 2000-12-11 | ||
| PCT/JP2001/010768 WO2002048141A1 (en) | 2000-12-11 | 2001-12-10 | Medicinal compositions improved in solublity in water |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002221096A1 true AU2002221096A1 (en) | 2002-06-24 |
Family
ID=18844590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002221096A Abandoned AU2002221096A1 (en) | 2000-12-11 | 2001-12-10 | Medicinal compositions improved in solublity in water |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040058956A1 (en) |
| EP (1) | EP1350792A1 (en) |
| KR (1) | KR20040025880A (en) |
| CN (1) | CN1487935A (en) |
| AU (1) | AU2002221096A1 (en) |
| CA (1) | CA2431319A1 (en) |
| HU (1) | HUP0401811A2 (en) |
| NO (1) | NO20032613L (en) |
| PL (1) | PL362979A1 (en) |
| WO (1) | WO2002048141A1 (en) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY169670A (en) | 2003-09-03 | 2019-05-08 | Tibotec Pharm Ltd | Combinations of a pyrimidine containing nnrti with rt inhibitors |
| EP1439178A4 (en) * | 2001-10-05 | 2005-11-16 | Takeda Pharmaceutical | HETEROCYCLIC COMPOUNDS, OXAZOLE DERIVATIVES, PROCESS FOR THEIR PRESENTATION AND USE THEREOF |
| RU2293721C2 (en) | 2002-02-28 | 2007-02-20 | Джапан Тобакко Инк. | Ester compounds and their using in medicine |
| WO2004096281A1 (en) * | 2003-04-29 | 2004-11-11 | Kowa Co., Ltd. | Composition containing medicine extremely slightly soluble in water being excellent in eluting property and method for preparation thereof |
| MY147403A (en) * | 2003-04-29 | 2012-11-30 | Kowa Co | Composition containing medicine extremely slightly solube in water and method for preparation thereof |
| US20060030623A1 (en) * | 2004-07-16 | 2006-02-09 | Noboru Furukawa | Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis |
| MY191349A (en) | 2004-08-27 | 2022-06-17 | Bayer Pharmaceuticals Corp | New pharmaceutical compositions for the treatment of hyper-proliferative disorders |
| US8101774B2 (en) * | 2004-10-18 | 2012-01-24 | Japan Tobacco Inc. | Ester derivatives and medicinal use thereof |
| BRPI0516772A (en) * | 2004-10-25 | 2008-09-23 | Japan Tobacco Inc | solid formulation with improved solubility and stability and method for producing said formulation |
| AU2005317047A1 (en) * | 2004-11-05 | 2006-06-22 | Cephalon, Inc. | Cancer treatments |
| US8436190B2 (en) | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| EP1767194A1 (en) * | 2005-06-09 | 2007-03-28 | Helm AG | Process for the preparation of adsorbates of drospirenone |
| WO2006137595A1 (en) * | 2005-06-24 | 2006-12-28 | Takeda Pharmaceutical Company Limited | Prophylactic/therapeutic agent for her2-expressing cancer |
| CA2622944A1 (en) * | 2005-09-30 | 2007-04-12 | F. Hoffmann-La Roche Ag | Diazine azole derivatives, their manufacture and use as pharmaceutical agents |
| KR100767349B1 (en) * | 2006-08-01 | 2007-10-17 | 삼천당제약주식회사 | Oral pharmaceutical composition containing fenofibrate and a method of manufacturing the same |
| TWI494133B (en) | 2007-03-14 | 2015-08-01 | Tibotec Pharm Ltd | Powders for reconstitution |
| AR072777A1 (en) | 2008-03-26 | 2010-09-22 | Cephalon Inc | SOLID FORMS OF BENDAMUSTINE CHLORHYDRATE |
| JP5670335B2 (en) * | 2008-09-25 | 2015-02-18 | セファロン、インク. | Bendamustine liquid formulation |
| BRPI1004922A2 (en) * | 2009-01-15 | 2019-09-24 | Cephalon Inc | pharmaceutical composition, crystalline form of the bendamustine free base and method of treatment of chronic lymphocytic leukemia, hodgkin's disease, non-hodgkin's lymphoma, multiple myeloma or breast cancer |
| EP2581084A4 (en) * | 2010-05-31 | 2014-06-25 | Astellas Pharma Inc | Solid dispersion comprising triazole compound |
| EP2642996B1 (en) | 2010-11-24 | 2020-09-23 | Melinta Subsidiary Corp. | Pharmaceutical compositions |
| WO2013056108A2 (en) * | 2011-10-14 | 2013-04-18 | Array Biopharma Inc. | Solid dispersion |
| CN103070828B (en) * | 2011-10-26 | 2016-01-27 | 山东新时代药业有限公司 | A kind of solid dispersion, tablet and preparation method thereof containing Abiraterone acetate |
| GB2516561B (en) * | 2013-03-15 | 2016-03-09 | Aerpio Therapeutics Inc | Compositions, formulations and methods for treating ocular diseases |
| CA2943024A1 (en) | 2014-03-18 | 2015-09-24 | Takeda Pharmaceutical Company Limited | Solid dispersion |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5352617A (en) * | 1976-10-25 | 1978-05-13 | Shin Etsu Chem Co Ltd | Solid drug coating composition |
| IT1183574B (en) * | 1985-05-08 | 1987-10-22 | Eurand Spa | METHOD FOR OBTAINING A HOMOGENEOUS ETHERPORARY SUSPENSION OF MICROCAPS |
| WO1996019239A1 (en) * | 1994-12-21 | 1996-06-27 | Yamanouchi Pharmaceutical Co., Ltd. | Solid composition with improved solubility and absorbability |
| DE69717831T3 (en) * | 1996-07-24 | 2018-08-30 | Celgene Corp. | SUBSTITUTED 2- (2,6-DIOXOPIPERIDIN-3-YL) -PHTHALIMIDES AND -1-OXOISOINDOLINES AND METHOD FOR REDUCING THE TNF-ALPHA MIRROR |
| EP0995435B1 (en) * | 1997-05-14 | 2007-04-25 | Senju Pharmaceutical Co., Ltd. | Aqueous suspension preparations with excellent redispersibility |
-
2001
- 2001-12-10 PL PL01362979A patent/PL362979A1/en not_active Application Discontinuation
- 2001-12-10 KR KR10-2003-7007740A patent/KR20040025880A/en not_active Withdrawn
- 2001-12-10 US US10/433,507 patent/US20040058956A1/en not_active Abandoned
- 2001-12-10 HU HU0401811A patent/HUP0401811A2/en unknown
- 2001-12-10 CN CNA018224024A patent/CN1487935A/en active Pending
- 2001-12-10 CA CA002431319A patent/CA2431319A1/en not_active Abandoned
- 2001-12-10 EP EP01270217A patent/EP1350792A1/en not_active Withdrawn
- 2001-12-10 WO PCT/JP2001/010768 patent/WO2002048141A1/en not_active Ceased
- 2001-12-10 AU AU2002221096A patent/AU2002221096A1/en not_active Abandoned
-
2003
- 2003-06-10 NO NO20032613A patent/NO20032613L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20032613D0 (en) | 2003-06-10 |
| CN1487935A (en) | 2004-04-07 |
| HUP0401811A2 (en) | 2004-12-28 |
| WO2002048141A1 (en) | 2002-06-20 |
| PL362979A1 (en) | 2004-11-02 |
| KR20040025880A (en) | 2004-03-26 |
| CA2431319A1 (en) | 2002-06-20 |
| NO20032613L (en) | 2003-08-05 |
| EP1350792A1 (en) | 2003-10-08 |
| US20040058956A1 (en) | 2004-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002221096A1 (en) | Medicinal compositions improved in solublity in water | |
| GB2358583B (en) | Pharmaceutical compositions | |
| AU2001268659A1 (en) | Water treatment compositions | |
| AU6219601A (en) | Pharmaceutical compositions | |
| GB0009584D0 (en) | Pharmaceutical compositions | |
| AU8576801A (en) | Pharmaceutical compositions | |
| AU2002214324A1 (en) | Medicinal compositions | |
| AU2001290239A1 (en) | Medicinal composition | |
| AU1390002A (en) | Pharmaceutical compositions | |
| GB0008485D0 (en) | Pharmaceutical compositions | |
| GB0009613D0 (en) | Pharmaceutical compositions | |
| AU8254101A (en) | Medicinal compositions | |
| AU2001282541A1 (en) | Medicinal compositions | |
| GB2363073B (en) | Oral rehydration formulation | |
| GB0006380D0 (en) | Polymer preparation | |
| GB0015361D0 (en) | Improvements in pharmaceutical compositions | |
| AU2002248155A1 (en) | Cleansing composition | |
| GB0023054D0 (en) | Improvements in aqueous compositions | |
| AUPQ523300A0 (en) | Improvements in water treatment compositions | |
| GB0015360D0 (en) | Improvements in pharmaceutical compositions | |
| AUPQ991200A0 (en) | Improvements in or relating to dispensers | |
| AUPQ432199A0 (en) | Improvements in water treatment compositions | |
| AUPQ271499A0 (en) | Improvements in water treatment compositions | |
| AUPQ999300A0 (en) | Improvements in water treatment | |
| AUPQ625800A0 (en) | Improvements in water treatment |